Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size.
Vincent CostalatTudor G JovinJ F AlbucherChristophe CognardHilde HenonNasreddine NouriBenjamin GorySebastien RichardGaultier MarnatIgor SibonFederico Di MariaMariam AnnanGrégoire BoulouisPere CardonaMichael ObadiaMichel PiotinRomain BourcierBenoit GuillonSophie GodardAnne Pasco-PaponOmer F EkerTae-Hee ChoGuillaume TurcOlivier NaggaraStéphane VelascoMatthias LamyFrédéric ClarençonSonia AlamowitchArturo RenuLaurent SuissaHervé BrunelJean-Christophe GentricSerge TimsitChantal LamyCyril ChivotFrancisco Macian-MontoroCharbel MounayerOzlem Ozkul-WermesterChrysanthi PapagiannakiValérie WolffRaoul PopAnna FerrierEmmanuel ChabertFrédéric RicolfiYannick BéjotElena Lopez-CancioPedro VegaLaurent SpelleChristian DenierMònica MillánJuan F ArenillasMichael MazighiEmmanuel HoudartMaria Del Mar FreijoAlain DuhamelNerses SanossianDavid S LiebeskindJulien LabreucheBertrand LapergueCaroline Arquizannull nullPublished in: The New England journal of medicine (2024)
In patients with acute stroke and a large infarct of unrestricted size, thrombectomy plus medical care resulted in better functional outcomes and lower mortality than medical care alone but led to a higher incidence of symptomatic intracerebral hemorrhage. (Funded by Montpellier University Hospital; LASTE ClinicalTrials.gov number, NCT03811769.).
Keyphrases
- acute ischemic stroke
- acute myocardial infarction
- risk factors
- atrial fibrillation
- study protocol
- brain injury
- cardiovascular events
- clinical trial
- phase iii
- randomized controlled trial
- type diabetes
- heart failure
- cardiovascular disease
- coronary artery disease
- left ventricular
- percutaneous coronary intervention
- acute coronary syndrome
- blood brain barrier
- subarachnoid hemorrhage